Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Qiagen N.V.
(NY:
QGEN
)
43.61
+0.03 (+0.07%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Qiagen N.V.
< Previous
1
2
3
4
5
6
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 21, 2022
Good morning, investor! We're back with a breakdown of the biggest pre-market stock movers for Tuesday to get the day started!
Via
InvestorPlace
U.S. CDC Endorses the Use of Digital PCR Technology for Wastewater Surveillance of Infectious Diseases – Including COVID-19 Outbreaks
June 01, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s Eco-Friendlier Products Earn Prestigious ACT Label
May 19, 2022
From
QIAGEN N.V.
Via
Business Wire
Natera Clocks 28% Jump In Q1 Sales, Lifts FY22 Guidance
May 06, 2022
Via
Benzinga
Qiagen Posts Upbeat Q1 Earnings, Raises FY22 Outlook
April 27, 2022
Via
Benzinga
QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
May 16, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Proposes Expansion of Supervisory Board
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR System
May 05, 2022
From
QIAGEN N.V.
Via
Business Wire
Earnings Scheduled For April 27, 2022
April 27, 2022
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.
Via
Benzinga
QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlook
April 26, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to release results for Q1 2022 and hold Webcast
April 20, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB
March 24, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Announces 20-F Annual Report Filing for 2021 Results
March 14, 2022
From
QIAGEN N.V.
Via
Business Wire
Death Cross Looms Over Qiagen Investors
February 17, 2022
If history is any guide, there may be trouble ahead for shares of Qiagen (NYSE:QGEN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...
Via
Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Qiagen Q4 Earnings Beat Expectations On High Demand For COVID-19 Tests, Issues FY22 Guidance
February 09, 2022
Qiagen N.V. (NYSE: QGEN)
Via
Benzinga
Qiagen: Q4 Earnings Insights
February 08, 2022
Qiagen (NYSE:QGEN) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Qiagen beat estimated earnings by...
Via
Benzinga
QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year sales growth from non-COVID products
February 08, 2022
From
QIAGEN N.V.
Via
Business Wire
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Qiagen's Earnings: A Preview
February 07, 2022
Qiagen (NYSE:QGEN) is set to give its latest quarterly earnings report on Tuesday, 2022-02-08. Here's what investors need to know before the announcement. Analysts estimate that Qiagen will likely...
Via
Benzinga
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
February 07, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s Commitment to LGBTQ+ and Gender Equality Recognized by Human Rights Campaign and Bloomberg Indexes
January 27, 2022
From
QIAGEN N.V.
Via
Business Wire
Earnings Scheduled For February 8, 2022
February 08, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance
January 25, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
January 19, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
January 18, 2022
From
QIAGEN N.V.
Via
Business Wire
What Does Qiagen's Debt Look Like?
January 13, 2022
Over the past three months, shares of Qiagen (NYSE:QGEN) moved lower by 5.06%. Before we understand the importance of debt, let us look at how much debt Qiagen has. Qiagen...
Via
Benzinga
QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version
January 10, 2022
From
QIAGEN N.V.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.